Total Payments
$1,363
2021 Payments
$139.00
Companies
16
Transactions
59
Medicare Patients
1,185
Medicare Billing
$113,933
Payment Breakdown by Category
Food & Beverage$1,223 (89.7%)
Education$89.99 (6.6%)
Other$50.00 (3.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,223 | 57 | 89.7% |
| Education | $89.99 | 1 | 6.6% |
| Grant | $50.00 | 1 | 3.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $268.21 | 17 | $0 (2021) |
| Janssen Biotech, Inc. | $187.64 | 12 | $0 (2021) |
| NeoTract Inc. | $165.09 | 2 | $0 (2020) |
| AbbVie Inc. | $134.53 | 8 | $0 (2020) |
| Endo Pharmaceuticals Inc. | $124.35 | 3 | $0 (2019) |
| SRS Medical Systems, Inc. | $92.58 | 1 | $0 (2018) |
| PFIZER INC. | $77.31 | 4 | $0 (2020) |
| Teleflex LLC | $55.09 | 1 | $0 (2021) |
| BOSTON SCIENTIFIC CORPORATION | $50.00 | 1 | $0 (2017) |
| Blue Earth Diagnostics Limited | $48.35 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $139.00 | 7 | Teleflex LLC ($55.09) |
| 2020 | $227.41 | 9 | NeoTract Inc. ($78.29) |
| 2019 | $488.97 | 23 | Astellas Pharma US Inc ($133.58) |
| 2018 | $457.43 | 19 | Janssen Biotech, Inc. ($93.05) |
| 2017 | $50.00 | 1 | BOSTON SCIENTIFIC CORPORATION ($50.00) |
All Payment Transactions
59 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/28/2021 | Astellas Pharma US Inc | MYRBETRIQ (Drug), XTANDI | Food and Beverage | In-kind items and services | $15.25 | General |
| Category: UROLOGY | ||||||
| 06/29/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $12.82 | General |
| Category: Oncology | ||||||
| 06/23/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: ONCOLOGY | ||||||
| 06/17/2021 | Teleflex LLC | UroLift System (Device) | Food and Beverage | In-kind items and services | $55.09 | General |
| Category: Interventional Urology | ||||||
| 05/18/2021 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Oncology | ||||||
| 02/17/2021 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $11.77 | General |
| Category: ONCOLOGY | ||||||
| 02/10/2021 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: ONCOLOGY | ||||||
| 11/19/2020 | NeoTract Inc. | UroLift (Device) | Food and Beverage | In-kind items and services | $78.29 | General |
| Category: Interventional Urology | ||||||
| 03/10/2020 | Aytu Bioscience, Inc | Natesto (Drug) | Food and Beverage | Cash or cash equivalent | $21.68 | General |
| Category: Urology | ||||||
| 02/24/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2020 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: ONCOLOGY | ||||||
| 02/18/2020 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.47 | General |
| Category: ENDOCRINOLOGY | ||||||
| 02/17/2020 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $27.57 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 02/04/2020 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: ONCOLOGY | ||||||
| 01/21/2020 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/20/2020 | TOLMAR Pharmaceuticals, Inc. | ELIGARD (Drug) | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Prostate Cancer | ||||||
| 11/19/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ONCOLOGY | ||||||
| 11/05/2019 | PFIZER INC. | TOVIAZ (Drug), XTANDI | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: GENITOURINARY (UROLOGY) | ||||||
| 10/24/2019 | AbbVie, Inc. | Lupron Depot (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Endocrinology | ||||||
| 10/08/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $14.74 | General |
| Category: ONCOLOGY | ||||||
| 09/03/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 08/28/2019 | 180 Medical, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.51 | General |
| 08/04/2019 | Astellas Pharma US Inc | XTANDI (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: ONCOLOGY | ||||||
| 06/25/2019 | Astellas Pharma US Inc | XTANDI (Drug), MYRBETRIQ | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: ONCOLOGY | ||||||
| 06/20/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 17 | 469 | 784 | $150,141 | $46,701 |
| 2020 | 18 | 716 | 1,270 | $246,134 | $67,233 |
Total Patients
1,185
Total Services
2,054
Medicare Billing
$113,933
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 102 | 133 | $18,221 | $9,445 | 51.8% |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | Office | 2021 | 15 | 208 | $14,560 | $7,299 | 50.1% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2021 | 25 | 30 | $19,770 | $5,675 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 37 | 46 | $9,292 | $4,358 | 46.9% |
| 51728 | Complex measurement of pressure of urine flow in bladder (cystometrogram) with voiding pressure studies | Office | 2021 | 14 | 14 | $15,400 | $4,062 | 26.4% |
| 87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | Office | 2021 | 15 | 48 | $4,800 | $3,370 | 70.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 32 | 32 | $6,720 | $2,705 | 40.3% |
| 76705 | Ultrasound of abdomen, limited | Office | 2021 | 28 | 37 | $10,434 | $2,651 | 25.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 15 | 15 | $2,700 | $2,179 | 80.7% |
| 52332 | Insertion of stent in urinary duct (ureter) using an endoscope | Facility | 2021 | 11 | 12 | $17,100 | $1,430 | 8.4% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2021 | 75 | 97 | $12,610 | $795.60 | 6.3% |
| 87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | Office | 2021 | 15 | 16 | $1,120 | $561.44 | 50.1% |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | Office | 2021 | 15 | 16 | $1,120 | $561.44 | 50.1% |
| 51784 | Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings | Office | 2021 | 15 | 15 | $4,875 | $478.19 | 9.8% |
| 74420 | Imaging of urinary tract | Facility | 2021 | 15 | 22 | $5,038 | $457.82 | 9.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 14 | 14 | $1,190 | $435.06 | 36.6% |
| 51741 | Electronic assessment of bladder emptying | Office | 2021 | 26 | 29 | $5,191 | $238.11 | 4.6% |
| 87798 | Detection test for organism | Office | 2020 | 17 | 338 | $23,660 | $11,860 | 50.1% |
| 51728 | Insertion of electronic device into bladder with voiding pressure studies | Office | 2020 | 28 | 35 | $34,134 | $8,867 | 26.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 118 | 161 | $27,231 | $8,492 | 31.2% |
| 52000 | Diagnostic examination of the bladder and bladder canal (urethra) using an endoscope | Office | 2020 | 40 | 46 | $30,910 | $7,155 | 23.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 64 | 79 | $21,489 | $5,815 | 27.1% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 47 | 47 | $21,892 | $5,776 | 26.4% |
| 87801 | Detection test for multiple organisms | Office | 2020 | 17 | 78 | $7,800 | $5,476 | 70.2% |
| 76705 | Ultrasound of abdomen | Office | 2020 | 42 | 50 | $15,445 | $3,424 | 22.2% |
About Dr. Atip Chatsudthipong, M.D
Dr. Atip Chatsudthipong, M.D is a Urology healthcare provider based in West Warwick, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1508126590.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Atip Chatsudthipong, M.D has received a total of $1,363 in payments from pharmaceutical and medical device companies, with $139.00 received in 2021. These payments were reported across 59 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($1,223).
As a Medicare-enrolled provider, Chatsudthipong has provided services to 1,185 Medicare beneficiaries, totaling 2,054 services with total Medicare billing of $113,933. Data is available for 2 years (2020–2021), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location West Warwick, RI
- Active Since 05/23/2012
- Last Updated 12/11/2020
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1508126590
Products in Payments
- XTANDI (Drug) $252.96
- UroLift (Device) $165.09
- Erleada (Drug) $146.05
- XIAFLEX (Biological) $124.35
- Spanner Prothetic Stent (Device) $92.58
- TOVIAZ (Drug) $77.31
- UroLift System (Device) $55.09
- Lupron Depot (Drug) $54.65
- GENERAL - ERECTILE DYSFUNCTION (Device) $50.00
- Axumin (Drug) $48.35
- PROVENGE (Drug) $45.92
- Lupron (Drug) $34.03
- LUPRON DEPOT (Drug) $30.76
- ERLEADA (Drug) $28.85
- Natesto (Drug) $21.68
- ELIGARD (Drug) $21.38
- SpaceOAR (Device) $17.03
- INTERSTIM (Device) $15.82
- MYRBETRIQ (Drug) $15.25
- Androgel (Drug) $15.09
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in West Warwick
Mark Leo, M.d, M.D
Urology — Payments: $13,442
Urology $13,442
Dr. Angelo Cambio, Md, MD
Urology — Payments: $12,271
Urology $12,271
Dr. Joseph Cambio, D.o, D.O
Urology — Payments: $11,054
Urology $11,054
Alexander Lubin, M.d, M.D
Urology — Payments: $4,051
Urology $4,051
Dr. Bruce Kilstein, D.o, D.O
Urology
Urology